GB1378348A - Orally administered drug composition for therapy in the treatment of narcotic drug addiction - Google Patents

Orally administered drug composition for therapy in the treatment of narcotic drug addiction

Info

Publication number
GB1378348A
GB1378348A GB1649072A GB1649072A GB1378348A GB 1378348 A GB1378348 A GB 1378348A GB 1649072 A GB1649072 A GB 1649072A GB 1649072 A GB1649072 A GB 1649072A GB 1378348 A GB1378348 A GB 1378348A
Authority
GB
United Kingdom
Prior art keywords
narcotic
treatment
drug addiction
therapy
amine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB1649072A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
WEST LABORATORIES Inc
Original Assignee
WEST LABORATORIES Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by WEST LABORATORIES Inc filed Critical WEST LABORATORIES Inc
Publication of GB1378348A publication Critical patent/GB1378348A/en
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0007—Effervescent
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Inorganic Chemistry (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
GB1649072A 1971-04-12 1972-04-10 Orally administered drug composition for therapy in the treatment of narcotic drug addiction Expired GB1378348A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US13334471A 1971-04-12 1971-04-12

Publications (1)

Publication Number Publication Date
GB1378348A true GB1378348A (en) 1974-12-27

Family

ID=22458150

Family Applications (1)

Application Number Title Priority Date Filing Date
GB1649072A Expired GB1378348A (en) 1971-04-12 1972-04-10 Orally administered drug composition for therapy in the treatment of narcotic drug addiction

Country Status (4)

Country Link
CA (1) CA982478A (da)
DE (1) DE2217132A1 (da)
FR (1) FR2132856B1 (da)
GB (1) GB1378348A (da)

Cited By (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1611880A2 (en) * 2004-06-30 2006-01-04 Ibsa Institut Biochimique S.A. Pharmaceutical formulations for the safe administration of drugs used in the treatment of drug addiction
WO2011106076A1 (en) 2010-02-24 2011-09-01 Medical Biological Union Llc Diversion-and/or abuse-resistant compositions and methods for making the same
US8362007B1 (en) 2010-05-11 2013-01-29 Demerx, Inc. Substituted noribogaine
US8637648B1 (en) 2010-06-22 2014-01-28 Demerx, Inc. Compositions comprising noribogaine and an excipient to facilitate transport across the blood brain barrier
US8741891B1 (en) 2010-06-22 2014-06-03 Demerx, Inc. N-substituted noribogaine prodrugs
US8765737B1 (en) 2010-05-11 2014-07-01 Demerx, Inc. Methods and compositions for preparing and purifying noribogaine
US8802832B2 (en) 2010-06-22 2014-08-12 Demerx, Inc. Compositions comprising noribogaine and an excipient to facilitate transport across the blood brain barrier
US8859764B2 (en) 2011-01-26 2014-10-14 Demerx, Inc. Methods and compositions for preparing noribogaine from voacangine
US8877921B2 (en) 2012-01-25 2014-11-04 Demerx, Inc. Synthetic voacangine
US8940728B2 (en) 2012-12-20 2015-01-27 Demerx, Inc. Substituted noribogaine
US9045481B2 (en) 2012-12-20 2015-06-02 Demerx, Inc. Substituted noribogaine
US9051343B2 (en) 2011-12-09 2015-06-09 Demerx, Inc. Phosphate esters of noribogaine
US9150584B2 (en) 2012-01-25 2015-10-06 Demerx, Inc. Indole and benzofuran fused isoquinuclidene derivatives and processes for preparing them
US9358237B2 (en) 2010-07-23 2016-06-07 Demerx, Inc. Noribogaine compositions
US9394294B2 (en) 2010-05-11 2016-07-19 Demerx, Inc. Methods and compositions for preparing and purifying noribogaine
US9550789B2 (en) 2014-06-18 2017-01-24 Demerx, Inc. Halogenated indole and benzofuran derivatives of isoquinuclidene and processes for preparing them
US9586954B2 (en) 2010-06-22 2017-03-07 Demerx, Inc. N-substituted noribogaine prodrugs
US9617274B1 (en) 2011-08-26 2017-04-11 Demerx, Inc. Synthetic noribogaine
US9783535B2 (en) 2012-12-20 2017-10-10 Demerx, Inc. Substituted noribogaine

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES8307096A1 (es) * 1981-06-01 1983-07-01 Orion Yhtymae Oy "un metodo para preparar tabletas a base de polvos de medicamento acidicos, inocuas para el esofago".
NL8400911A (nl) * 1984-03-22 1985-10-16 Dagra Nv Werkwijze ter bereiding van een farmaceutische toedieningsvorm die tetracycline of doxycyclinezouten bevat.
ATE265213T1 (de) 1997-09-04 2004-05-15 Novoneuron Inc Noribogain zur behandlung von schmerzen und drogenabhängigkeit
US7220737B1 (en) 1997-09-04 2007-05-22 Novoneuron, Inc Noribogaine in the treatment of pain and drug addiction

Cited By (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1611880A3 (en) * 2004-06-30 2006-09-13 Altergon S.A. Pharmaceutical formulations for the safe administration of drugs used in the treatment of drug addiction
EP1611880A2 (en) * 2004-06-30 2006-01-04 Ibsa Institut Biochimique S.A. Pharmaceutical formulations for the safe administration of drugs used in the treatment of drug addiction
CN102883600B (zh) * 2010-02-24 2015-11-25 尹温斯博生物技术有限责任公司 抗改向和/或抗滥用的组合物及其制备方法
WO2011106076A1 (en) 2010-02-24 2011-09-01 Medical Biological Union Llc Diversion-and/or abuse-resistant compositions and methods for making the same
EP2538779A1 (en) * 2010-02-24 2013-01-02 Medical Biological Union LLC Diversion-and/or abuse-resistant compositions and methods for making the same
CN102883600A (zh) * 2010-02-24 2013-01-16 医学生物学联合有限责任公司 抗改向和/或抗滥用的组合物及其制备方法
EP2538779A4 (en) * 2010-02-24 2013-08-21 Medical Biolog Union Llc DIVERSION AND / OR ABUSE MATERIAL COMPOSITIONS AND METHOD FOR THEIR MANUFACTURE
US8362007B1 (en) 2010-05-11 2013-01-29 Demerx, Inc. Substituted noribogaine
US9394294B2 (en) 2010-05-11 2016-07-19 Demerx, Inc. Methods and compositions for preparing and purifying noribogaine
US8765737B1 (en) 2010-05-11 2014-07-01 Demerx, Inc. Methods and compositions for preparing and purifying noribogaine
US9308272B2 (en) 2010-06-22 2016-04-12 Demerx, Inc. Compositions comprising noribogaine and an excipient to facilitate transport across the blood brain barrier
US9586954B2 (en) 2010-06-22 2017-03-07 Demerx, Inc. N-substituted noribogaine prodrugs
US8637648B1 (en) 2010-06-22 2014-01-28 Demerx, Inc. Compositions comprising noribogaine and an excipient to facilitate transport across the blood brain barrier
US8802832B2 (en) 2010-06-22 2014-08-12 Demerx, Inc. Compositions comprising noribogaine and an excipient to facilitate transport across the blood brain barrier
US8741891B1 (en) 2010-06-22 2014-06-03 Demerx, Inc. N-substituted noribogaine prodrugs
US9358237B2 (en) 2010-07-23 2016-06-07 Demerx, Inc. Noribogaine compositions
US9403817B2 (en) 2011-01-26 2016-08-02 Demerx, Inc. Methods and compositions for preparing noribogaine from voacangine
US8859764B2 (en) 2011-01-26 2014-10-14 Demerx, Inc. Methods and compositions for preparing noribogaine from voacangine
US9617274B1 (en) 2011-08-26 2017-04-11 Demerx, Inc. Synthetic noribogaine
US9051343B2 (en) 2011-12-09 2015-06-09 Demerx, Inc. Phosphate esters of noribogaine
US9150584B2 (en) 2012-01-25 2015-10-06 Demerx, Inc. Indole and benzofuran fused isoquinuclidene derivatives and processes for preparing them
US9469649B2 (en) 2012-01-25 2016-10-18 Demerx, Inc. Synthetic voacangine
US8877921B2 (en) 2012-01-25 2014-11-04 Demerx, Inc. Synthetic voacangine
US9045481B2 (en) 2012-12-20 2015-06-02 Demerx, Inc. Substituted noribogaine
US8940728B2 (en) 2012-12-20 2015-01-27 Demerx, Inc. Substituted noribogaine
US9783535B2 (en) 2012-12-20 2017-10-10 Demerx, Inc. Substituted noribogaine
US9550789B2 (en) 2014-06-18 2017-01-24 Demerx, Inc. Halogenated indole and benzofuran derivatives of isoquinuclidene and processes for preparing them

Also Published As

Publication number Publication date
CA982478A (en) 1976-01-27
FR2132856A1 (da) 1972-11-24
DE2217132A1 (de) 1972-10-26
FR2132856B1 (da) 1975-04-25

Similar Documents

Publication Publication Date Title
GB1378348A (en) Orally administered drug composition for therapy in the treatment of narcotic drug addiction
EP0067130A3 (en) Capsules containing the active principle of an allergen, and process for their preparation
MY102459A (en) Oral sustained release pharmaceutical preparation.
DE3773468D1 (de) Hydromorphon-zusammensetzung mit gesteuerter wirkstofffreisetzung.
KR840000229A (ko) 디피리다몰의 경구용 제형의 제조방법
ATE43497T1 (de) Pharmazeutische formulierung mit gesteuerter absorption.
Castell et al. Nephrogenic diabetes insipidus due to demethylchlortetracycline hydrochloride
JPS5767518A (en) Radiosensitizing agent or agent for increasing effect of radiomimetic substance
ATE8739T1 (de) Pharmazeutische zubereitungen.
ATE47518T1 (de) Injizierbare pharmazeutische zusammenstellungen die bestaendige 5-adenosyl-l-methionin-salze enthalten.
SU1814764A3 (ru) Способ получения средства для лечения гнойно-некротических ран
NO841372L (no) Fremgangsmaate for fremstilling av dipyridamol-preparater med ph-uavhengig regulert frigjoering
Ivey et al. Effect of intravenous salicylates on the gastric mucosal barrier in man
ES427653A1 (es) Procedimiento para la preparacion de nuevos acidos 3-hidro- xiacilaminometil-5-acilamino-2, 4, 6-triyodo-benzoicos.
YU120291A (sh) Preparati herbicida
GB1254057A (en) Improvements in or relating to therapeutical composition containing vincamine
GB1420976A (en) Pharmaceutical compositions for use in the treatment of certain respiratory diseases or conditions in prematurely born children
FR2329260A1 (fr) Nouvelles pierres a lecher
GB1283505A (en) Substituted alkanol-thioalkyl-amines
GB1386927A (en) Preparations for combatting swine dysentery
GB1284884A (en) A new insoluble salt of kanamycin
EP0153171A3 (en) New 2-hydroxyethyl-trimethylammonium salt of 1-ethyl-3-carboxy-4-oxo-6,7-methylenedioxy-1,4-dihydroquinoline, process for the preparation thereof and pharmaceutical composition containing it
GB1330993A (en) Mixture of l-dopa and 2-imino-5-phenyl-4-oxazolidinone used to treat parkinsons disease
FR2340952A1 (fr) Procede de preparation d'un alcaloide de type di-indol ou ses sels d'additions avec un acide, pharmaceutiquement actifs, ainsi que des compositions pharmaceutiques le contenant
ES8502439A1 (es) Un metodo de preparar una forma solida, estable y soluble en agua de 3-desazaguanina

Legal Events

Date Code Title Description
PS Patent sealed
PLNP Patent lapsed through nonpayment of renewal fees